Navigation Links
Hospira Reports Third-Quarter 2009 Results
Date:10/27/2009

slightly up.

During the third quarter, Hospira recognized an income tax benefit on the expiration of statutes of limitation on certain unrecognized tax benefits. The tax benefit was partially offset by the tax effect of the U.S. launch of oxaliplatin. Based on these factors, the company is adjusting the guidance for its 2009 effective tax rate to 20 to 21 percent from the prior guidance of 21 to 22 percent.

As a result, the company now expects full-year 2009 adjusted* diluted earnings per share to be between $2.85 and $2.90 per share. The reconciliation between the projected 2009 adjusted* diluted earnings per share and GAAP diluted earnings per share follows:

    Diluted earnings per share -- adjusted*                     $2.85 - $2.90
                                                                -------------
    Estimated charges related to Project Fuel
    initiatives (mid-point of an estimated range of
    $0.34 to $0.38 per diluted share for
    non-impairment charges, plus incurred
    year-to-date impairment and other asset
    charges of $0.37 per diluted share)                                ($0.73)

    Estimated charges related to facilities optimization
    initiatives (mid-point of an estimated range of
    $0.10 to $0.12 per diluted share)                                  ($0.11)

    Estimated $53 million for the amortization of
    intangibles related to the Mayne Pharma acquisition                ($0.23)

    Impairment of marketable equity securities                         ($0.10)

    Tax benefit from the settlement of a U.S. income tax audit          $0.57
                                                                -------------

    Diluted earnings per share -- GAAP                          $2.25 - $2.30
                                                                =============

The company now projects that cash flow from operations in 2009 will be in the $700 million to $750 million ran
'/>"/>

SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine technology :

1. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
2. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
3. Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric Drugs
4. Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11
5. Hospira Names Daphne E. Jones Chief Information Officer
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... BC , March 31, 2015 /CNW/ - T-Bird Pharma ... focused on developing premium quality medical marijuana products and ... Marihuana for Medical Purposes Regulations ( Canada ... received notice from The Corporation of the District of ... approval of the Company,s premises which now allows for ...
(Date:3/31/2015)... 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... the development and commercialization of a once-daily, oral ... cholesterol gallstones, today announced financial results for the ... Fourth Quarter 2014 Highlights: , Hosted a ... by Professor Rohit Loomba, MD, MHSc., who discussed ...
(Date:3/31/2015)... , March 31, 2015   Unique Pharmaceuticals , ... is complete and the company has initiated sterile compounding ... "Our goal as a company is to meet and ... Leeah . "Meeting the new regulations is validation of ... embracing the future of our industry, investing in its ...
Breaking Medicine Technology:T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 2Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 3Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 4Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 5Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 6Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 7Galmed Pharmaceuticals Reports Full Year 2014 Financial Results and Provides Business Update 8Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3
... 2011 Edison Pharmaceuticals, Inc. announced today the ... orphan drug designation to EPI-743 for treatment of ... diseases affect an estimated 60,000 individuals. ... incentives for companies to pursue treatments for diseases ...
... 2011 PolyOne Corporation (NYSE: POL ) ... to develop non-lead radiation shielding components for Siemens, newest ... this week at the Medical Design & Manufacturing (MD&M) ... Center in New York City. Using PolyOne,s ...
Cached Medicine Technology:Edison Pharmaceuticals Announces FDA Grants EPI-743 Orphan Drug Designation 2
(Date:3/31/2015)... Creek, Michigan (PRWEB) March 31, 2015 On ... retired NFL All-Pro Lawrence Taylor to discuss the problem of ... Taylor, through his own history of drug abuse and recovery, ... process. , Nicknamed “L.T.” by his teammates on the New ... the league due to failed drug tests, yet he was ...
(Date:3/31/2015)... 2015 Cosmetic Town, one of the ... proudly enduring adding news to its site while it ... of plastic surgery and cosmetic medicine better use and ... interconnected sections, the Cosmetic Town community is tingling at ... Cosmetic Town site navigation, News and Blog section, will ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 The American ... events. The schedule for April will include interesting workshops, ... New Student Orientation, 9-11 a.m. April 6, ACTCM welcomes ... Room D at the Pioneer Square Campus located at ... Aid, 12:30-1:30 p.m. April 14, Students will be updated ...
(Date:3/31/2015)... Calling all runners, walkers and everyone who ... diseases! The first annual “Lyme Walk & Run” will be ... CT. The event, hosted by Lyme Research Alliance (LRA) ... to support research and education about Lyme and other tick-borne ... and abilities, will feature 5K and 10K runs and one-mile ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Medical DNA ... has met all criteria for Laboratory Accreditation by COLA, ... only to laboratories that apply rigid standards of quality ... of proficiency testing, and pass a rigorous on-site laboratory ... accreditation as a result of a long-term commitment to ...
Breaking Medicine News(10 mins):Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Cosmetic Town is Now Transforming so Consumer can Better Navigate 2Health News:ACTCM Announces April Event Schedule 2Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2
... authored an editorial in the July 27 online issue of ... JNCI ) commenting on results of an analysis of the ... The cost effectiveness analysis concluded that CTC or "virtual" colonoscopy ... the same rate as colonoscopy. Both CT colonography and ...
... Louisville, Ky. Smaller, rural hospitals may be quicker ... their larger, urban counterparts, and are capable of providing ... with major hospitals that provide a comprehensive array of ... led by researchers from the University of Louisville Department ...
... cell that has broken free from a tumor and is ... seem like finding a needle in a haystack. But a ... first step toward making this possible. UW researchers have developed ... more precise form of medical imaging essentially erasing the ...
... Reporter , MONDAY, July 26 (HealthDay News) -- Extending the ... tPA from 3 hours to up to 4.5 hours after ... in treatment and appears to be a safe option for ... slight increased risk of death and bleeding over a three-month ...
... HealthDay Reporter , MONDAY, July 26 (HealthDay News) ... the sniff to help severely disabled people play computer games, ... The experimental "sniff controller" takes advantage of the fact ... and are still able to send messages to the soft ...
... The ranks of China,s millionaires continue to grow, but ... country,s gross domestic happiness, according to psychologists at the ... prosperity in the nation is fast outpacing mental health ... by spreading the science of happiness in China. ...
Cached Medicine News:Health News:UNC physician authors editorial on cost-effectiveness study for colon cancer screening 2Health News:Smaller hospitals can provide safe and high-quality surgical care comparable to larger counterparts 2Health News:Smaller hospitals can provide safe and high-quality surgical care comparable to larger counterparts 3Health News:Multifunctional nanoparticle enables new type of biological imaging 2Health News:Multifunctional nanoparticle enables new type of biological imaging 3Health News:Longer Time Frame for Clot-Busting Drug May Help Beat Stroke 2Health News:Longer Time Frame for Clot-Busting Drug May Help Beat Stroke 3Health News:Sniffing Device Allows Disabled to Write, Run Wheelchairs 2Health News:Sniffing Device Allows Disabled to Write, Run Wheelchairs 3Health News:UC Berkeley psychologists bring science of happiness to China 2Health News:UC Berkeley psychologists bring science of happiness to China 3Health News:UC Berkeley psychologists bring science of happiness to China 4
For primary and revision cases...
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
Implex cemented hip stem....
Medicine Products: